Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00914381 · ClinicalTrials.gov registry record · Phase 2

Behavioral Treatment for Cocaine Dependent Women

A Phase 2 study of Cocaine Dependence, sponsored by Yale University.

Completed
Registry status
Phase 2
Development phase
145
Enrollment target
2
Study locations

NCT00914381 is a Phase 2 study of Cocaine Dependence that has completed, run by Yale University. The registered enrollment target is 145 participants, below the 295-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00914381, a Phase 2 study of Cocaine Dependence, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 2
Development phase
145 participants
Enrollment target
2
Study locations

Study Summary

To compare the efficacy of Community Reinforcement Approach (CRA) and 12-Step Facilitation (TSF) counseling and of voucher based reward therapy (VBRT) and a yoked, non-contingent voucher control (VC) for the treatment of cocaine dependent pregnant women or women with young children.

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral therapy

Study Locations (2)

Connecticut

  • The APT Foundation, Inc. MRU - New Haven
  • Yale University School of Medicine - New Haven

Trial Details

FieldValue
Enrollment Target 145 participants
Start Date 1994-12
Est. Completion 2002-03
Phase Phase 2

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT00914381

The ClinicalTrials.gov registry entry for NCT00914381 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 295-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (51% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cocaine Dependence appearing as the primary indexed condition, and to 1 intervention - of which Behavioral therapy is the first listed.

NCT00914381 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00914381 about?

NCT00914381 is a clinical study titled "Behavioral Treatment for Cocaine Dependent Women". To compare the efficacy of Community Reinforcement Approach (CRA) and 12-Step Facilitation (TSF) counseling and of voucher based reward therapy (VBRT) and a yoked, non-contingent voucher control (VC) for the treatment of cocaine dependent pregnant women or women with young children.

What is the current status of trial NCT00914381?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 145 participants. The study started on 1994-12. Estimated completion is 2002-03.

What conditions does trial NCT00914381 study?

This clinical trial studies the following conditions: Cocaine Dependence.

What interventions are being tested in trial NCT00914381?

The interventions under investigation include: Behavioral therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00914381?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00914381 being conducted?

This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cocaine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.